Thursday, September 19, 2019
wellness India Expo
Home Tags Quarter 4

Tag: Quarter 4

Jubilant Life Sciences YoY revenue up by 21% at 9,111 crore

While the company recorded the year on year revenue growth up to 21 percent standing ar Rs 9,111 crore and EBITDA up by 14% to Rs 1,775 crore. The normalized PAT stood at Rs 855 crore. During the fourth quarter, revenue was Rs 2,386 crore and normalized PAT was at Rs 135 Crore................

Syngene delivers sustained growth in its Quarter 4 results

The company's revenue grows 31 percent to Rs 334 crore and EBITA is up by 23 percent to Rs 106 crore...